FDA Import Refusal 1FX-1775094-5/10002/11 — ORISON PHARMA INTL
The FDA refused shipment 1FX-1775094-5/10002/11 from ORISON PHARMA INTL (India) on Sep 22, 2026. The refused product falls under Drugs and Biologics — OFLOXACIN (ANTI-BACTERIAL, PART II) (NOT ANTIBIOTIC). Cited charge: 75 This firm has 3 other import refusals on record.
Refusal Details
- Date
- Sep 22, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61GDA85 OFLOXACIN (ANTI-BACTERIAL, PART II) (NOT ANTIBIOTIC)
- Charges
- 75